New Research from the CWMH: Evaluating the Risk of Major Malformations in Children Prenatally Exposed to Atypical Antipsychotics
Despite the increasing use of the newer “atypical” or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little data on the reproductive safety of these newer atypical agents. In response to this deficit, the National Pregnancy Registry for Atypical Antipsychotics was created to evaluate the safety of atypical antipsychotic medications taken by women during pregnancy. [...]
Weekly Roundup for JUNE 3 2016: Recent Publications in Women’s Mental Health
This week’s highlights include one study looking at the effects of methylphenidate on pregnancy outcomes and an interesting 30-year follow-up study from Myrna Weissman and colleagues on the children of depressed parents. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt [...]
In Brief: Telephone-Based CBT for Menopause-Related Insomnia
Peri- and postmenopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes. While nocturnal hot flushes may be the cause of sleep disruption in many peri- and postmenopausal women, many of these women have an underlying primary sleep disorder, like restless leg syndrome or sleep apnea. Various pharmacologic and non-pharmacologic interventions may be used to manage sleep disturbance in this population The [...]
Mirtazapine (Remeron) for Hyperemesis Gravidarum
Nausea and vomiting of pregnancy (NVP) or “morning sickness” affect up to 90% of women. The symptoms are usually worse in the morning for most, but not all, women. Nausea and vomiting typically begin around weeks 8 of gestation and subside after 12–14 weeks. However, in about 10% of pregnancies, women continue to experience nausea and vomiting beyond 20 weeks of gestation and sometimes even until delivery. Hyperemesis Gravidarum (HG) is [...]
Weekly Roundup for MAY 27 2016: Publications in Reproductive Psychiatry
Mirtazapine in pregnancy and lactation - A systematic review. Smit M, Dolman KM, Honig A. Eur Neuropsychopharmacol. 2016 Jan;26(1):126-35. Pregnancy outcome following maternal exposure to pregabalin may call for concern. Winterfeld U, Merlob P, Baud D, Rousson V, et al. Neurology. 2016 May 18. REVIEWED ON OUR WEBSITE MATERNAL DEPRESSION AND CHILD OXYTOCIN RESPONSE; MODERATION BY MATERNAL OXYTOCIN AND RELATIONAL BEHAVIOR. Pratt M, Apter-Levi Y, Vakart A, Feldman M, Fishman [...]
Post-Adoption Depression: How Common? Who is At Risk?
While we tend to think of postpartum depression (PPD) as a hormonally driven mood disorder in women, multiple studies have suggested that, although men do not experience any of the dramatic physiological or hormonal changes that go along with pregnancy, new fathers may also suffer from PPD. There are perhaps elements of caring for a new baby which may increase vulnerability to depression in all parents, male or female. We [...]